ORIC Pharmaceuticals (ORIC) News Today → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free ORIC Stock Alerts $9.17 +0.28 (+3.15%) (As of 05/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 5.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.5%May 13, 2024 | americanbankingnews.comORIC Pharmaceuticals, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.42) Per Share (NASDAQ:ORIC)May 11, 2024 | marketbeat.comMonaco Asset Management SAM Trims Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Monaco Asset Management SAM lessened its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 27.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 280,000 shares of the compMay 10, 2024 | marketbeat.comORIC Pharmaceuticals, Inc. to Post Q1 2025 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:ORIC)ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for ORIC Pharmaceuticals in a note issued to investors on Wednesday, May 8th. HC Wainwright analyst R. Burns anticipates that the company will post earnings perMay 8, 2024 | markets.businessinsider.comBuy Rating on Oric Pharmaceuticals Amidst Strong Financials and Promising Clinical PipelineMay 8, 2024 | morningstar.comORIC Pharmaceuticals IncMay 8, 2024 | finance.yahoo.comWe Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business GrowthMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Oric Pharmaceuticals Amid Promising Clinical Data and Strong Financial PositionMay 7, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Oric Pharmaceuticals (ORIC)May 7, 2024 | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Buy" by AnalystsORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price amongMay 7, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 6.5%May 6, 2024 | investorplace.comORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024May 6, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 3.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 3.5%May 6, 2024 | globenewswire.comORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational UpdatesMay 3, 2024 | globenewswire.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 30, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.8%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.8%April 24, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.6%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 5.6%April 18, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 4%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 4%April 17, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 4.2%ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 4.2%April 15, 2024 | globenewswire.comORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLCApril 8, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 2.6% ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 2.6%April 8, 2024 | globenewswire.comORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual MeetingApril 5, 2024 | globenewswire.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 4, 2024 | globenewswire.comORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesApril 1, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 6.3%ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 6.3%March 29, 2024 | seekingalpha.comORIC Pharmaceuticals: Rally Seems OverdoneMarch 27, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) PT Lowered to $18.00JPMorgan Chase & Co. decreased their target price on ORIC Pharmaceuticals from $19.00 to $18.00 and set an "overweight" rating for the company in a research report on Wednesday.March 21, 2024 | markets.businessinsider.comOric Pharmaceuticals: Sustained Buy Rating Amid Strong Financials and Upcoming CatalystsMarch 21, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Analyst UpgradeORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up After Analyst UpgradeMarch 21, 2024 | marketbeat.comHC Wainwright Increases ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $21.00HC Wainwright lifted their price objective on ORIC Pharmaceuticals from $15.00 to $21.00 and gave the stock a "buy" rating in a research report on Thursday.March 14, 2024 | investing.comORIC Pharmaceuticals stock target raised to $17 on strong prospectsMarch 13, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading 7.9% Higher ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 7.9%March 13, 2024 | seekingalpha.comORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To GainsMarch 12, 2024 | finance.yahoo.comORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial ResultsMarch 12, 2024 | marketbeat.comEuclidean Capital LLC Raises Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Euclidean Capital LLC boosted its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 32.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 989,410 shaMarch 12, 2024 | markets.businessinsider.comThese Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 ResultsMarch 12, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Issues Earnings Results, Hits EstimatesORIC Pharmaceuticals (NASDAQ:ORIC - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.49) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.49).March 11, 2024 | msn.comORIC Pharmaceuticals GAAP EPS of -$0.49March 11, 2024 | globenewswire.comORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational UpdatesMarch 8, 2024 | finance.yahoo.comORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 SharesMarch 8, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 5.5% ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.5%March 7, 2024 | finance.yahoo.comORIC Mar 2024 2.500 putMarch 6, 2024 | finance.yahoo.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | globenewswire.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | globenewswire.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Hits New 12-Month High at $16.10ORIC Pharmaceuticals (NASDAQ:ORIC) Reaches New 1-Year High at $16.10March 5, 2024 | globenewswire.comORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingMarch 5, 2024 | marketbeat.comFmr LLC Sells 600,054 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Fmr LLC trimmed its holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 16.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,132,194 shares of the company's stock after selling 600,0March 4, 2024 | marketbeat.comAcadian Asset Management LLC Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Acadian Asset Management LLC lessened its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 86.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,691 shares of the company's stock after selling 147,797 shares during the pMarch 3, 2024 | finance.yahoo.comORIC Apr 2024 10.000 call Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… ORIC Media Mentions By Week ORIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼0.800.43▲Average Medical News Sentiment ORIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼02▲ORIC Articles Average Week Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Savara News Today Arbutus Biopharma News Today Pharming Group News Today Harrow News Today Avid Bioservices News Today Phathom Pharmaceuticals News Today Aerovate Therapeutics News Today Zymeworks News Today Calliditas Therapeutics AB (publ) News Today Mineralys Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis could mean the end of the U.S dollar…Colonial MetalsTruth about Trump you’ve never heardPorter & CompanyGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media$1,500 to $9,400 in one month? (A.I. Trade List)Prosper Trading AcademyAlex’s “Next Magnificent Seven” stocksThe Oxford ClubNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
